Introduction {#s1}
============

Acute respiratory infection (ARI) is the leading infectious cause of under-five mortality worldwide.[@R1] Up to 40% of ARIs diagnosed and treated as bacterial pneumonias in the developing world are bronchiolitis caused by respiratory syncytial virus (RSV)[@R2]; antibiotics may be unnecessary. Studies in Kenya examining the burden of RSV in paediatric admissions, mainly from the rural coastal town of Kilifi, show a range between 15% and 34%.[@R3]

Seasonal epidemics, local climate, malnutrition, HIV, urbanisation and vaccination uptake are some factors affecting aetiology of ARIs within Africa.[@R2] Bronchiolitis aetiology and prevalence is thus likely to be influenced by varying geographical, temporal and population factors within the different regions of Kenya.

This study aimed to determine the prevalence of RSV infection in children admitted with bronchiolitis to five hospital sites within Kenya.

Methods {#s2}
=======

A multi-centre prospective cross-sectional prevalence study was conducted across five hospitals within central and highland Kenya.

Children admitted to hospital younger than 24 months old fulfilling the WHO definition of bronchiolitis were eligible for this study.[@R6] Patients were recruited from April to June 2015, coinciding with the annual clinical peak of ARIs across all sites. Consented patients were tested for RSV at the bedside using RSV rapid immunochromatographic assay testing kits donated by US company Alere (BinaxNOW RSV card) on nasopharyngeal swab specimens.

Secondary data on demographics, symptomatology and clinical signs were collected.

Patient and Public Involvement (PPI) {#s2a}
------------------------------------

Patients were not directly involved in the design of this study.

Results {#s3}
=======

Two hundred and sixty-six patients were eligible to be recruited to the study. 12% of parents declined consent. Two hundred and thirty-four patients were successfully recruited. The overall RSV positive rate was 8.1%. Demographic, geographical and study data are shown in [table 1](#T1){ref-type="table"} and [figure 1](#F1){ref-type="fig"}.
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###### 

Demographic characteristics and results of the five Kenyan study hospitals in 2015

  Hospital                                 1\. Chogoria                                        2\. Karatina                                                   3\. Nanyuki                                                         4\. Narok                     5\. Kiambu                                                                        Total
  ---------------------------------------- --------------------------------------------------- -------------------------------------------------------------- ------------------------------------------------------------------- ----------------------------- --------------------------------------------------------------------------------- -----------
  Hospital type                            Level 2 private missionary                          Level 4 government referral                                    Level 4 government referral                                         Level 4 government referral   Level 4 government referral                                                       
  District population                      365 300                                             693 558                                                        400 000                                                             820 920                       1 623 282                                                                         
  Annual paediatric admissions (approx.)   2000                                                1375                                                           2800                                                                1700                          3600                                                                              11 475
  Official paediatric bed capacity         43                                                  24                                                             24                                                                  32                            49                                                                                172
  Number declined                          1                                                   7                                                              5                                                                   8                             11                                                                                32
  Number recruited                         8                                                   59                                                             29                                                                  50                            88                                                                                234
  RSV positive cases                       0 (0%)                                              1 (1.7%)                                                       3 (10.3%)                                                           7 (14%)                       8 (9.1%)                                                                          19 (8.1%)
  Main challenges encountered              Unable to recruit daily, needing paternal consent   Unable to recruit daily, parental concerns re: pain/bleeding   Language barriers (Maasai interpreters), needing paternal consent   Needing paternal consent      Availability of nasopharyngeal swabs, parental concerns regarding pain/bleeding   

RSV positive rates varied widely across study hospitals: 0% in Chogoria, 1.7% in Karatina, 10.3% in Nanyuki, 9% in Kiambu and 14% in Narok, respectively. However, the small number of positive cases was not enough to power statistical analysis between the sites (19/234 cases).

57.7% of participants were male. 41% were under 6 months of age. The mean average age of all participants was 8.7 months; average age of RSV-positive cases was 3.9 months and RSV-negative 9.2 months. Difficulty feeding was a positive predictor of RSV (OR=3.33, 95% CI (1.25 to 8.83), p\<0.01); however, the sample size was not large enough to control for age. No other clinical signs were statistically significantly associated with an RSV-positive test.

Discussion {#s4}
==========

This is the first published study to look at RSV prevalence rates in children admitted with bronchiolitis across central and highland Kenya. It found an RSV positive prevalence of 8.1%; this is much lower than previously reported rates in other Kenyan studies, including those also only using immunochromatographic testing. Prevalence also appears to vary significantly between regions, which could be explained by environment, altitude, climate, level of urbanisation, access to healthcare and tribal cultures. Although recruitment coincided with peak annual ARI cases, RSV epidemics could have occurred at other times.

The mean age of RSV-positive cases was 5 months younger than RSV-negative cases. The only statistically significant sign or symptom associated with RSV was difficulty in feeding; however, the sample size was not large enough to control for age. Sample size was limited due to availability of recruiting clinicians.

Given the burden of disease, further studies looking at the viral aetiologies of ARIs and timings of epidemics, are required across the different areas in Kenya. A better understanding of the epidemiology of RSV infections could help guide evidence-based guidelines, management (including antimicrobial stewardship) and public health planning, such as potential vaccine developments.
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